Neogen’s first quarter results were shaped by contrasting trends across its business lines. Management cited continued core growth in the Food Safety segment, particularly in the United States, while acknowledging significant supplier-driven disruptions in the Animal Safety business. CEO Mikhael Nassif noted, “We encountered several supplier challenges stemming from third-party manufacturers that unfortunately had a meaningful impact on our Animal Safety business.” The company responded by strengthening supplier qualification processes and implementing operational improvements to support reliability and efficiency.
Is now the time to buy NEOG? Find out in our full research report (it’s free for active Edge members).
Neogen (NEOG) Q1 CY2026 Highlights:
- Revenue: $211.2 million vs analyst estimates of $204.3 million (4.4% year-on-year decline, 3.4% beat)
- Adjusted EPS: $0.09 vs analyst estimates of $0.05 (68.8% beat)
- Adjusted EBITDA: $25.62 million vs analyst estimates of $40.71 million (12.1% margin, 37.1% miss)
- The company slightly lifted its revenue guidance for the full year to $858.5 million at the midpoint from $850 million
- EBITDA guidance for the full year is $175 million at the midpoint, above analyst estimates of $170.8 million
- Operating Margin: -1.6%, down from 2.4% in the same quarter last year
- Market Capitalization: $2.05 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Neogen’s Q1 Earnings Call
- Subhalaxmi Nambi (Guggenheim): asked about unexpected supply chain costs and the timeline for resolution in Animal Safety. CEO Mikhael Nassif emphasized that supplier challenges were being addressed through stronger qualification processes but cautioned that some disruptions could persist into the next quarter.
- Bob Labick (CJS Securities): questioned whether core Food Safety growth was sustainable and how to interpret the company’s guide. Nassif reiterated that commercial execution was driving current results and that resource reallocation would further support growth, with more specifics to be shared at the upcoming Investor Day.
- Brandon Vazquez (William Blair): inquired about the impact of recent operational changes and the potential for larger commercial adjustments. Nassif explained that changes underway were additive rather than disruptive, focused on aligning resources with high-opportunity markets.
- Thomas DeBourcy (Nephron Research): asked about the sustainability of gross margin improvements and the financial impact of the genomics business sale. CFO Bryan Riggsbee confirmed margin gains were mix-driven and the divestiture would be accretive.
- David Westenberg (Piper Sandler): pressed for details on margin expansion opportunities beyond Petrifilm. Riggsbee pointed to improvements in sample collection, cost structure optimization, and inventory management as additional margin drivers for the coming year.
Catalysts in Upcoming Quarters
In the coming quarters, key catalysts will include (1) the pace of Petrifilm manufacturing transition and its impact on margins, (2) the resolution of supply chain challenges within the Animal Safety segment, and (3) progress from commercial leadership changes and the new solutions-based selling approach. Execution on these fronts, along with sustained innovation in Food Safety products, will be central to Neogen’s ability to deliver on its transformation plan.
Neogen currently trades at $9.42, down from $10.34 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free).
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
